Your “Heart-Healthy” Glass of Red Was an Ad.

Ask a table of adults why a nightly glass of red is fine, or better than fine, and someone will eventually say the French thing. The French eat butter and cheese and duck fat, the French smoke, and yet the French have low rates of heart disease, so the secret must be in the glass. It sounds like folk wisdom. It sounds like something peasants in Bordeaux have known for six hundred years.

It is thirty-five years old, and it premiered on a Sunday night.

Sixty minutes, twenty million households, one sales chart

Morley Safer walked viewers through the puzzle, a French researcher named Serge Renaud supplied the science, and the segment landed on its answer with a glass of red wine practically glowing in the frame. The wine, it suggested, was why the French could eat like that and outlive the rest of us.

The country responded the way a country responds when the most trusted news program in America tells it that its favorite indulgence is medicine. The demand did not fade when the news cycle did.

Here is the detail that earns the word "ad." The wine industry had been pushing health-benefit messaging for years before that broadcast and getting nowhere with it, because a health claim from a wine seller sounds like exactly what it is. Then a news program delivered the same message for free, wrapped in journalistic credibility, to an audience no media buy could have reached. Nobody at CBS was on the take. It did not matter. A claim does not need to be purchased to function as advertising. It just needs to sell.

What the camera left out

The paradox had a hole in it, visible at the time to anyone who looked. France in that era had some of the developed world's worst alcohol-related mortality, cirrhosis very much included, running higher than the United States. The segment's framing, wine as the protective secret of the French, required not dwelling on what all that wine was doing to French livers. Decades later, a Wine Spectator editor reviewing the episode's legacy put it plainly: the picture was selective.

That is the part worth sitting with. The French Paradox was not a fraud. It was a partial picture broadcast to a country that badly wanted to hear it, and a health claim that flatters your existing habit will always travel faster than the correction chasing it. The correction, in this case, took about three decades to arrive.

The J-curve had a body in the denominator

The broadcast supplied the story, but the scientific respectability came from something called the J-curve: decade after decade of studies finding that moderate drinkers outlived people who did not drink at all. Plotted on a chart, mortality risk dipped at a drink or two a day before climbing, a shape that looked like permission.

The problem was hiding in who counted as a non-drinker. Those comparison groups were salted with what researchers call sick quitters, people who had stopped drinking because they were already ill. Compare moderate drinkers against a group that includes the already-sick and the drinkers look protected, when much of what you are measuring is that they have not gotten sick yet.

In 2023, Zhao, Stockwell, and Naimi published a re-analysis in JAMA Network Open covering the field's accumulated evidence.

Correct for the sick-quitter problem and related biases, and the apparent protective effect largely disappears. The floor under thirty years of wine-with-dinner confidence, the dip in the J, was substantially an artifact of who got sorted into which group.

Before you swing the other way

Now the part we always include and most coverage does not. The correction is contested too.

That matters right now because we are living through the mirror image of 1991. Sweeping certainty is back, pointed the other way this time: no-safe-amount headlines, warning-label campaigns, a new consensus arriving with the same confidence the old one had. Some of it rests on far stronger ground than a Sunday-night TV segment. And some of it is the same move with the sign flipped. The lesson of the French Paradox was never "distrust wine." It is that whenever a health claim shows up at exactly the moment somebody needs it to be true, your first question should be who needed it.

Which brings us to our own shelf, because the non-alcoholic aisle is not innocent here. It is currently growing its own halo, all adaptogens and calm-in-a-can, and plenty of it would not survive the same scrutiny the J-curve did not. We hold the drinks we carry to a simpler standard: they have to be good enough to order on taste, with no health story doing the heavy lifting. If a drink needs a halo to sell, it does not make the list.